Policies & Transparency
Our commitments to ethical, transparent and equitable scholarly publishing for the international clinical and academic community.
Our publishing commitments
JOCASS is an international, peer-reviewed, open-access journal. Editorial decisions are made independently and on scholarly merit, with transparency, confidentiality and research integrity at the centre of our process.
Open access · current fees
Published articles are freely accessible immediately upon publication, without an embargo, subscription or reader registration. No submission or publication fees are currently charged.
Independent double-blind review
Manuscripts are evaluated through double-blind peer review, by at least two independent external experts.
Ethics and integrity
Our editorial practice follows recognised principles of COPE, ICMJE and WAME, alongside the journal’s official policies.
Editorial and peer-review practice
Fair editorial assessment
Submissions are assessed for relevance, quality, originality and ethical soundness, without discrimination on personal or institutional grounds.
Confidentiality and conflicts
Editors and reviewers must protect manuscript confidentiality and declare any competing interests. Those with a conflict do not take part in the decision.
Corrections and concerns
Concerns are assessed carefully. When needed, the published record may be clarified through corrections, expressions of concern or retractions.
For corrections or publication ethics concerns, contact editor@jocass.org. Please identify the article and describe your concern.
Special issues and guest editors
As of 16 October 2026, JOCASS does not currently publish special issues. The following policy will apply to any future special issues, supplements or collections curated by guest editors.
- Scope and editorial responsibility: All proposals must be approved by the Editor-in-Chief and fall within the journal’s aims and scope. The Editor-in-Chief retains overall responsibility for all journal content, including special issues.
- Guest-editor appointment and oversight: The Editor-in-Chief will verify and approve guest editors’ qualifications, expertise and declared competing interests before appointment. The Editor-in-Chief or designated editorial board members will supervise their work throughout the editorial process.
- Independent peer review: Special-issue manuscripts must meet the same editorial, ethical and quality standards as regular submissions, including double-blind assessment by at least two independent external reviewers. Invitations do not guarantee acceptance. The Editor-in-Chief retains final editorial authority; where a conflict exists, decisions are delegated to an independent senior editor.
- Clear identification: Special issues and their articles will be clearly labelled. The issue or collection page will identify its scope, guest editors and affiliations, and any funding or sponsorship. Sponsors must not influence peer review or publication decisions.
- Guest editors as authors: Manuscripts authored or co-authored by a guest editor must be handled by an independent editor with no conflict of interest. The authoring guest editor must not select reviewers, manage the review or participate in the decision. Articles authored or co-authored by any guest editor, counted collectively, must constitute no more than 25% of the issue’s total articles.
- Consistent journal policies: The journal’s published policies on conflicts of interest, open access, licensing, author charges, complaints and corrections also apply to special issues. Any applicable charges or sponsorship must be disclosed before submission.
Policy effective: 16 October 2026. Proposals and enquiries: editor@jocass.org.
Author responsibilities
Originality and authorship
Authors are responsible for original work, accurate citation, appropriate authorship and disclosure of contributions. An active ORCID iD is required for each author, as specified in the author guidelines.
Ethics, consent and privacy
Research involving people or animals requires relevant ethical approval, informed consent and protection of personal or participant information.
Reporting and data
Use appropriate reporting guidance where relevant and include a clear data-availability statement. Clinical trials should be registered when applicable.
Generative AI and AI-assisted technologies
AI-assisted tools may support scholarly work only where their use is transparent, responsible and compatible with research integrity.
- Generative AI tools cannot be listed as authors and cannot accept responsibility for a manuscript.
- Permitted AI language-editing use must be disclosed in the cover letter and manuscript acknowledgments, specifying the tool, version and purpose. AI used as part of the research methodology must be described in the Methods section.
- Authors remain fully responsible for accuracy, originality, citations, confidentiality and the absence of fabricated or misleading content.
- Reviewers and editors must not upload confidential manuscripts, reports or correspondence to external AI tools. Authors must protect participant data and other confidential information.
- AI-generated or AI-modified manuscript images and graphical abstracts are not permitted, except where AI is explicitly part of the research methodology under the official policy. AI-generated cover art requires prior written approval and clear attribution.
Copyright, licensing and preservation
Copyright and publication rights
Authors retain copyright and grant JOCASS the right of first publication and the non-exclusive rights necessary to publish, reproduce, distribute, communicate and archive the article in print and electronic formats. Copyright and economic rights are not transferred to the journal.
Digital preservation and archive access
Published articles are available in the JOCASS archive. All issues of JOCASS are digitally preserved through DergiPark using the LOCKSS (Lots of Copies Keep Stuff Safe) system for long-term preservation. The publisher also maintains backup copies of journal files.
Policy updates
Policies are reviewed as standards and editorial practice evolve. The dated copyright and licensing transition below defines the scope of this update.
Publisher and editorial independence
Owner and publisher: Merthan Tunay (individual publisher), Adana, Türkiye.
Publisher correspondence address: Adana City Training and Research Hospital, Dr. Mithat Özsan Bulvarı, Kışla Mah. 4522 Sok. No: 1, Yüreğir / Adana, Türkiye.
Contact person: Merthan Tunay · editor@jocass.org.
The hospital address is used for correspondence only; the hospital is not identified as the journal’s owner, publisher or sponsor.
Funding and financial support
All journal operating expenses are funded solely by Merthan Tunay from personal resources. The journal currently receives no institutional funding or external sponsorship. No submission or publication fees are charged. Financial support does not confer influence over peer review, manuscript acceptance or publication priority. This statement describes the journal’s funding, not the funding of individual research articles, which authors must disclose separately.
Publisher and funding information confirmed: 16 October 2026.
Editorial decisions are based on scholarly merit and remain independent of commercial interests. Editors with a conflict of interest must not handle the affected submission; responsibility is assigned to another editor under the journal’s published policy.
Advertising and sponsorship policy
Advertising enquiries may be sent to editor@jocass.org. Reserved banner spaces are placeholders, not evidence of an existing sponsor or endorsement.
- Only clearly identified advertising relevant to the journal’s professional readership may be considered. Misleading claims, guaranteed-publication offers and material incompatible with research integrity are not accepted.
- The publisher is responsible for advertising acceptance. Paid content must be labelled “Advertisement” or “Sponsored” and kept separate from research articles and editorial judgments.
- Advertisements must not obstruct article access or be presented as scientific findings. Placement must not be determined by manuscript acceptance decisions, confidential submission information or reviewer reports.
- Advertising or sponsorship must not influence reviewer selection, editorial decisions or publication priority. Advertising does not constitute endorsement by the journal.
- Before a campaign is displayed, its sponsor and any targeting or tracking arrangements must be disclosed. Sponsorship associated with a publication must be identified alongside that content.
Policy published: 16 October 2026.
Repository deposit, appeals and corrections
Self-archiving
The official open-access policy permits deposit of the accepted manuscript or published version immediately upon publication, with acknowledgment and a link to the original article. Earlier articles retain their original terms. Read the repository and licensing policy.
Appeals and complaints
Send a written appeal or complaint to editor@jocass.org, identifying the manuscript or article and providing reasons and supporting evidence. Rejection appeals should address the editorial and reviewer comments. The journal follows its published ethics procedures.
Post-publication discussion
Readers may submit a Letter to the Editor about published work. Significant errors are assessed for a linked correction, expression of concern or retraction as appropriate; substantive changes must not silently replace the scholarly record.
Open-access licence and transition
Articles covered by this policy are published under the Creative Commons Attribution-NonCommercial 4.0 International licence (CC BY-NC 4.0). This permits sharing and adaptation for non-commercial purposes with appropriate attribution, a link to the licence and an indication of changes. No additional restrictions are imposed beyond the licence. Third-party material excluded from the licence must be identified with its applicable terms.
Current author fees
No submission or publication fees are currently charged, including article processing, editorial processing, page or colour charges. Any future fees, their effective date and applicable waiver or discount arrangements will be announced before submission and will apply only to submissions received under the announced fee policy. Fee status, payment or waivers will not influence editorial decisions.
Article copyright and licence notice
New articles covered by this policy must display the same copyright owner and licence in their HTML, PDF and associated licence metadata: © [year] The Author(s). Published by JOCASS. Licensed under CC BY-NC 4.0. Link the licence to https://creativecommons.org/licenses/by-nc/4.0/ and identify any excluded third-party material.
Official policy documents
The complete policies are available on this website. Use the links below to open the relevant section.
Full policy library
Read the complete journal policies below. Select a heading to expand its text. Manuscript submission is the only service that opens DergiPark.
Publication ethics, complaints and corrections
Journal of Cukurova Anesthesia and Surgical Sciences (J Cukurova Anesth Surg )
1. Guiding Principles
The Journal of Cukurova Anesthesia and Surgical Sciences is committed to upholding the highest standards of publication ethics. All parties involved in the publication process — authors, editors, peer reviewers, and the publisher — are expected to comply with the principles established by the Committee on Publication Ethics (COPE; https://publicationethics.org), the International Committee of Medical Journal Editors (ICMJE; https://www.icmje.org), and the World Association of Medical Editors (WAME; https://www.wame.org).
In cases of suspected misconduct, the journal follows COPE guidelines and flowcharts for handling complaints and allegations: https://publicationethics.org/guidance/Flowcharts
2. Responsibilities of Authors
2.1. Scientific Responsibility
All submitted manuscripts must represent original work that complies with research and publication ethics. Authors are fully responsible for the content of their submissions. By submitting a manuscript, all authors confirm that:
- The work has not been published previously in any language, in whole or in part
- The work is not currently under consideration or review at any other journal
- All authors have read and approved the final version of the manuscript
- The corresponding author acts as the representative of all authors in all editorial correspondence and is responsible for the accuracy of the final submitted version
2.2. Authorship
Authorship must be based on all four ICMJE criteria:
- Substantial contributions to conception or design, or acquisition, analysis, or interpretation of data
- Drafting or critically revising the manuscript for important intellectual content
- Final approval of the version to be published
- Agreement to be accountable for all aspects of the work
All individuals listed as authors must meet all four criteria. Contributors who do not meet all criteria should be acknowledged in the Acknowledgments section. Guest authorship, gift authorship, and ghost authorship are forms of misconduct and will not be tolerated. Any changes to authorship after submission must be approved in writing by all authors and justified to the editor.
2.3. Ethical Approval for Human Studies
All research involving human participants must be conducted in accordance with the principles of the Declaration of Helsinki (https://www.wma.net/policies-post/wma-declaration-of-helsinki/). Authors must state in the Materials and Methods section that:
- The study was approved by an institutional ethics committee
- The name of the ethics committee, the approval number, and the date of approval are provided
- Written informed consent was obtained from all participants (or their legal guardians)
Retrospective studies, audits, and studies using anonymized data are not exempt from ethics review. If a study was granted an exemption, this must also be stated with the relevant committee details.
2.4. Ethical Approval for Animal Studies
Studies involving animals must comply with the ARRIVE 2.0 guidelines (https://arriveguidelines.org) and the Guide for the Care and Use of Laboratory Animals (https://grants.nih.gov/grants/olaw/guide-for-the-care-and-use-of-laboratory-animals.pdf). Authors must state that institutional ethics committee approval was obtained and that animal welfare was upheld throughout the study.
2.5. Informed Consent for Case Reports
For case reports or any manuscript containing identifiable patient information (including images, clinical histories, or genetic data), written informed consent from the patient or their legal guardian must be obtained for publication. Authors must confirm this in the manuscript. If consent could not be obtained, the reason must be stated and the editor’s approval sought.
2.6. Clinical Trial Registration
All clinical trials must be prospectively registered in a publicly accessible registry approved by the WHO International Clinical Trials Registry Platform (ICTRP; https://www.who.int/clinical-trials-registry-platform) before recruitment begins (e.g., ClinicalTrials.gov, ISRCTN). The trial registration number must be included at the end of the abstract. The journal will not consider unregistered clinical trials for publication.
2.7. Reporting Guidelines
Authors are expected to follow relevant reporting guidelines:
- Randomized controlled trials: CONSORT (https://www.consort-statement.org)
- Systematic reviews and meta-analyses: PRISMA (https://www.prisma-statement.org)
- Observational studies: STROBE (https://www.strobe-statement.org)
- Diagnostic accuracy studies: STARD (https://www.equator-network.org/reporting-guidelines/stard/)
- Case reports: CARE (https://www.care-statement.org)
Completed checklists should be uploaded as supplementary files at the time of submission.
2.8. Conflict of Interest
All authors must disclose any financial or personal relationships that could be perceived to influence the work. This includes but is not limited to: employment, consultancy fees, stock ownership, honoraria, expert testimony, research funding, travel grants, patents, and board memberships. Disclosures must be made on the title page and in a dedicated Conflict of Interest section at the end of the manuscript. If no conflicts exist, authors must state: “The authors declare no conflict of interest.”
2.9. Funding Disclosure
All sources of financial support must be disclosed, including grant names and numbers. If the study received no funding, authors must state: “This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.” Funders must not have had any role in study design, data collection, analysis, interpretation, or the decision to publish unless explicitly stated.
2.10. Data Availability
Authors are encouraged to make their underlying research data publicly available in an appropriate repository (e.g., Zenodo, Figshare, OSF) and to include a Data Availability Statement at the end of the manuscript. Where data cannot be shared, a brief explanation must be provided.
2.11. Use of Artificial Intelligence (AI) Tools
The use of AI-based language tools (e.g., large language models such as ChatGPT) for the preparation or editing of manuscripts must be disclosed in the cover letter and in the Methods or Acknowledgments section, specifying the tool used and the nature of its use. AI tools may not be listed as authors under any circumstances, as they cannot fulfill the ICMJE authorship criteria and cannot be held accountable for the work.
2.12. Duplicate Publication and Salami Slicing
Submitting a manuscript that substantially overlaps with previously published work — in any language — constitutes duplicate publication and is a form of research misconduct. Dividing the findings of a single study into multiple manuscripts to artificially increase the number of publications (salami slicing) is similarly prohibited. Authors who have published related work must disclose this at the time of submission and provide copies of the related publications for editorial review.
2.13. Simultaneous Submission
Submitting a manuscript to more than one journal simultaneously is not permitted. Authors must confirm that the manuscript is not under consideration elsewhere. If the manuscript is based on a thesis or conference presentation, this must be disclosed.
3. Responsibilities of Editors
3.1. Editorial Decisions
Editorial decisions to accept, revise, or reject a manuscript are based solely on the manuscript’s scientific merit, originality, clarity, and relevance to the journal’s scope. Decisions are not influenced by the authors’ nationality, institutional affiliation, race, gender, religious beliefs, or political views, nor by commercial interests or relationships with the publisher.
3.2. Confidentiality
Editors treat all submitted manuscripts as confidential documents. The content, status, and reviewer identities of submitted manuscripts must not be disclosed to anyone other than the authors, reviewers, and relevant editorial staff. Editors must not use unpublished material from submitted manuscripts in their own research without the explicit written consent of the authors.
3.3. Handling Conflicts of Interest
Editors must recuse themselves from handling manuscripts in which they have a conflict of interest (e.g., manuscripts submitted by their own students, collaborators, or institutional colleagues). In such cases, editorial responsibilities are delegated to another member of the editorial team.
3.4. Timeliness
Editors are committed to processing manuscripts in a timely manner. Authors are informed of the editorial decision within approximately 6–8 weeks of submission. If a decision is delayed beyond this period, the corresponding author will be notified.
3.5. Appeals and Complaints
Authors who wish to appeal a rejection decision may do so by submitting a formal written appeal to the editorial office, providing a detailed rebuttal of the reviewers’ and editors’ comments. Appeals are considered at the discretion of the editor-in-chief. Complaints regarding editorial conduct, reviewer behavior, or publication ethics may be submitted to the editorial office and will be handled in accordance with COPE guidelines.
4. Responsibilities of Peer Reviewers
4.1. Confidentiality
Peer reviewers must treat manuscripts as confidential documents. Reviewers must not share, discuss, or disclose the content of manuscripts under review with any third party. Manuscripts must not be retained after the review is complete; all copies (digital and physical) must be deleted or destroyed.
4.2. Conflict of Interest
Reviewers must immediately notify the editor if they have any conflict of interest with the authors, institutions, or content of the manuscript and must decline to review in such cases.
4.3. Objectivity and Constructiveness
Reviewers are expected to provide objective, evidence-based, and constructive evaluations. Personal criticism of the authors is not appropriate. Reviews should clearly identify the strengths and weaknesses of the manuscript and provide specific suggestions for improvement.
4.4. Timeliness
Reviewers are expected to respond to review invitations promptly and to submit their evaluations within the agreed timeframe (typically 3–4 weeks). If a reviewer is unable to complete the review within this period, they should notify the editor immediately so that an alternative reviewer can be appointed.
4.5. Recognition of Reviewers
The journal acknowledges the contribution of peer reviewers. A list of reviewers who have contributed to each volume is published on the journal website at the end of each calendar year.
5. Plagiarism Policy
J Cukurova Anesth Surg Sci is committed to publishing only original work. All submitted manuscripts are screened for plagiarism using dedicated similarity detection software prior to peer review.
5.1. Thresholds and Actions
- Similarity below 15%: Manuscript proceeds to peer review
- Similarity between 15–25%: Manuscript is returned to authors for revision before further processing
- Similarity above 25%: Manuscript is rejected without peer review; authors are notified and advised to resubmit only after substantial revision
These thresholds apply to overall similarity excluding references, quoted material, and boilerplate text. The editorial board reserves the right to exercise judgment beyond these thresholds based on the nature and distribution of overlapping text.
5.2. Self-Plagiarism
Reproducing substantial portions of one’s own previously published work without appropriate citation and without the permission of the original copyright holder constitutes self-plagiarism. This includes recycling of Methods sections, Introduction text, or Results from prior publications. Authors must obtain permission from the original publisher and clearly indicate when previously published text is being reused.
5.3. Plagiarism Detected Before Publication
If plagiarism is detected at any stage before publication, the corresponding author will be notified and given an opportunity to respond. Depending on the severity of the overlap, the manuscript may be returned for revision or rejected outright. If the plagiarism is deliberate and extensive (>25%), the authors’ institution and relevant funding agencies may be informed.
5.4. Plagiarism Detected After Publication
If plagiarism is identified after publication, the journal will conduct a formal investigation in accordance with COPE guidelines. If misconduct is confirmed, the article will be retracted, a retraction notice will be published, and the authors’ institution and funding bodies will be notified.
6. Research Misconduct
The journal treats the following as serious forms of research misconduct:
- Fabrication: Inventing data, results, or findings that were not obtained
- Falsification: Manipulating research materials, equipment, processes, or data such that the research is not accurately represented
- Image manipulation: Altering figures or images in ways that misrepresent the original data
- Undisclosed duplication: Submitting the same work to multiple journals simultaneously or publishing the same data in more than one article without disclosure
- Improper authorship: Guest, gift, or ghost authorship
Allegations of research misconduct will be investigated in accordance with COPE guidelines. The journal reserves the right to contact authors’ institutions, funding agencies, and relevant professional bodies.
7. Corrections and Retractions
7.1. Corrections (Erratum/Corrigendum)
If a published article contains a significant error that does not affect the integrity of the findings, a correction notice will be published. Erratum notices address errors made by the journal; Corrigendum notices address errors made by the authors.
7.2. Retractions
An article will be retracted if:
- There is clear evidence of fabrication, falsification, or plagiarism
- The findings have been previously published without proper acknowledgment
- The study was conducted without required ethical approvals
- The authorship is disputed and cannot be resolved
Retraction notices will clearly state the reason for retraction and will remain permanently linked to the original article. The retracted article will be watermarked on all pages of the PDF but will remain accessible for the scientific record.
7.3. Expressions of Concern
In cases where an investigation is ongoing or where evidence is inconclusive, the editor may publish an Expression of Concern to alert readers while the matter is being resolved.
8. Post-Publication Discussion
The journal welcomes Letters to the Editor in response to published articles. Authors of the original article will be invited to respond. This correspondence will be published in a subsequent issue to foster scientific dialogue and transparency.
Copyright, licensing and fees updated 11 September 2026. All articles are freely accessible online immediately upon publication. Authors retain copyright and grant JOCASS the right of first publication and the non-exclusive rights necessary to publish, reproduce, distribute, communicate and archive the article in print and electronic formats. Copyright and economic rights are not transferred to the journal. Articles first published by JOCASS on or after 12 September 2026 are licensed under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0), permitting non-commercial sharing and adaptation with attribution, a licence link and an indication of changes. Earlier published articles retain their original copyright and licence terms. No submission or publication fees are currently charged. Full policy: https://jocass.org/policies-transparency/ Effective 12 September 2026, this policy applies prospectively to articles first published by JOCASS on or after that date. Articles published before that date retain the copyright and licence terms stated on the individual article at the time of publication. Previously signed agreements are not amended automatically; for unpublished manuscripts covered by an earlier transfer form, an updated publication licence must be agreed before publication under the new policy. No submission or publication fees are currently charged, including article processing, editorial processing, page or colour charges. Any future fees, their effective date and applicable waiver or discount arrangements will be announced before submission and will apply only to submissions received under the announced fee policy. Fee status, payment or waivers will not influence editorial decisions. For questions regarding publication ethics, contact the editorial office at editor@jocass.org or use the JOCASS contact page.
Submission and peer-review process
Overview
All manuscripts submitted to J Cukurova Anesth Surg must be prepared and conducted in accordance with the recommendations of the International Committee of Medical Journal Editors (ICMJE; https://www.icmje.org) and the ethical standards of the Committee on Publication Ethics (COPE; https://publicationethics.org).
All submissions are screened using a plagiarism detection program prior to peer review. A minimum of two independent, double-blind peer reviewers with recognized expertise in the relevant subject area are assigned by the editors for each manuscript.
1. Responsibilities of Authors
1.1. General Obligations
Authors must comply with all authorship criteria and conflict of interest disclosure requirements as defined by ICMJE (https://www.icmje.org/conflicts-of-interest/) and COPE (https://publicationethics.org/files/code_of_conduct_for_journal_editors_mar11.pdf). By submitting a manuscript to J Cukurova Anesth Surg, authors confirm that:
- The manuscript represents original work that has not been published previously in any language or format
- The manuscript is not currently under review at any other journal
- All authors have read and approved the final submitted version
- The corresponding author takes responsibility for the accuracy and completeness of the work on behalf of all co-authors
1.2. Predatory and Pseudo-Journals
A growing number of entities present themselves as legitimate scholarly journals while failing to meet basic standards of scientific publishing. These predatory or pseudo-journals typically accept manuscripts indiscriminately for a fee, falsely claim to conduct peer review, and may deliberately adopt names similar to well-established journals. They may also falsely claim membership of or compliance with ICMJE, COPE, or WAME.
Authors are responsible for evaluating the integrity, reputation, and publishing practices of any journal to which they submit their work. Resources to assist in identifying reputable peer-reviewed journals include:
- WAME: http://www.wame.org/identifying-predatory-or-pseudo-journals
- WAME Principles of Transparency: http://www.wame.org/about/principles-of-transparency-and-best-practice
- ICMJE member list: https://www.icmje.org/about-icmje/faqs/icmje-journals/
Consulting experienced colleagues and scientific mentors is also strongly recommended.
2. Responsibilities of the Journal
2.1. Confidentiality
All submitted manuscripts are the private, confidential property of the authors. Premature or unauthorized disclosure of manuscript content can cause serious harm to authors. Accordingly, J Cukurova Anesth Surg adheres to the following confidentiality standards:
- Editors must not share any information about a submitted manuscript — including its receipt, content, review status, reviewer critiques, or final decision — with anyone other than the authors and assigned reviewers
- Requests from third parties to access manuscripts or review reports for legal or other purposes must be refused; editors must make every effort not to provide such materials even if subpoenaed
- Reviewers and all editorial staff are required to treat manuscripts and all associated information as strictly confidential; they must not publicly discuss authors’ work or use authors’ ideas before publication
- Reviewers must not retain manuscripts for personal use; all physical copies must be destroyed and all electronic copies deleted upon submission of the review
- Upon rejection, journal editorial systems should delete copies of manuscripts unless local regulations require retention; where rejected manuscripts are retained, this practice must be disclosed in the Author Guidelines
- Upon publication, the journal will retain records of original submissions, reviewer reports, revisions, and correspondence for a minimum of three years, and potentially in perpetuity, in accordance with applicable regulations
- Reviewer identities are protected under the journal’s double-blind peer review policy and must not be disclosed to authors or third parties without the reviewer’s explicit written consent
- Reviewer comments must not be published or shared publicly without the consent of both the reviewer and the author
- Confidentiality may be breached only in cases of suspected or confirmed research misconduct; in such cases, the relevant parties will be notified before any disclosure is made
2.2. Timeliness
J Cukurova Anesth Surg is committed to processing all manuscripts in a timely and efficient manner. Editors will endeavor to communicate initial decisions within 6–8 weeks of submission. If publication will be delayed for any reason, this will be communicated to and negotiated with the authors. Manuscripts that are not suitable for the journal will be rejected as promptly as possible, allowing authors to pursue submission elsewhere without unnecessary delay.
2.3. Peer Review
J Cukurova Anesth Surg operates a rigorous double-blind peer review process in which the identities of both authors and reviewers are concealed throughout the review. Each manuscript is evaluated by a minimum of two independent external reviewers with recognized expertise in the relevant field.
Key aspects of the journal’s peer review process:
- The editorial team is responsible for identifying and selecting appropriate reviewers, free from conflicts of interest
- Reviewers are provided with all materials relevant to the evaluation, including supplementary files
- Reviewer comments are assessed and interpreted in the context of each reviewer’s declared conflicts of interest
- The journal is under no obligation to send every submitted manuscript for external review; the editor-in-chief retains the right to reject a manuscript at any stage, including after acceptance, if concerns arise regarding the integrity of the work
- Final editorial decisions are the responsibility of the editor-in-chief and may take into account factors beyond scientific quality, such as relevance to the journal’s scope
- Reviewers are notified of the final editorial decision and their contributions are acknowledged on the journal website at the end of each volume year
- Editors are encouraged to share reviewer comments among co-reviewers of the same manuscript to support mutual learning and consistency
- Editors are encouraged to request research protocols, statistical analysis plans, and project-specific contracts where relevant, and to promote public availability of such documents at the time of or following publication
- The journal supports post-publication scientific dialogue; readers may submit comments, questions, or criticisms regarding published articles through the Letters to the Editor mechanism, and authors are expected to respond appropriately
2.4. Editorial Integrity
Editorial decisions at J Cukurova Anesth Surg are based solely on the scientific merit, originality, clarity, and relevance of the manuscript to the journal’s scope. Decisions are not influenced by:
- Commercial interests or relationships with the publisher
- Personal relationships or prior history with the authors
- The nationality, institutional affiliation, race, gender, or religious beliefs of the authors
- Whether the findings are statistically significant, positive, or confirmatory of accepted views
Studies with negative, null, or inconclusive findings are considered equally for publication. Such studies contribute meaningfully to the scientific record, support future meta-analyses, and help prevent unnecessary duplication of research effort.
J Cukurova Anesth Surg maintains a transparent appeals and complaints process. Authors who wish to appeal a rejection decision must submit a written rebuttal to the editorial office detailing their response to the reviewers’ and editors’ concerns. All complaints are handled in accordance with COPE guidelines.
2.5. Journal Metrics
J Cukurova Anesth Surg acknowledges that journal metrics such as the impact factor are frequently misused as proxies for research quality or as measures of individual researchers’ merit in contexts such as hiring, promotion, and funding decisions. In line with ICMJE recommendations, the journal does not endorse the use of the impact factor as a singular measure of quality and encourages the use of a broader range of article- and journal-level metrics when evaluating the significance of published work.
3. Responsibilities of Peer Reviewers
3.1. Confidentiality
Manuscripts submitted for peer review remain the confidential property of the authors. Reviewers must treat all manuscripts and associated materials as strictly confidential throughout and after the review process. Reviewers must not:
- Publicly discuss or disclose the content of manuscripts under review
- Use or appropriate authors’ ideas, data, or conclusions prior to publication
- Retain manuscripts for personal use beyond the review period
- Upload any portion of a manuscript to external tools, platforms, or AI systems
All copies of manuscripts — physical and electronic — must be securely destroyed or deleted upon submission of the review report.
3.2. Objectivity and Constructiveness
Reviewers are expected to provide honest, evidence-based, and constructive evaluations. Reviews must focus on the scientific content of the manuscript and must not include personal criticism of the authors. Specific and actionable recommendations for improvement are strongly encouraged.
3.3. Timeliness
Reviewers are expected to respond promptly to review invitations and to submit their completed evaluations within the agreed timeframe, typically within 3–4 weeks of accepting the invitation. Reviewers who are unable to complete a review within the agreed period must notify the editorial office immediately so that an alternative reviewer can be appointed without delay.
3.4. Conflict of Interest
Reviewers must declare any potential conflicts of interest — including personal, financial, professional, or institutional relationships with the authors or their institutions — before accepting a review invitation. Reviewers with a conflict of interest must recuse themselves from the peer-review process for that manuscript.
For further information on submission requirements and publication standards, please refer to the Author Guidelines and Ethical Principles and Publication Policy pages on this website.
Generative AI and AI-assisted technologies
Journal of Cukurova Anesthesia and Surgical Sciences (J Cukurova Anesth Surg )
Overview
The Journal of Cukurova Anesthesia and Surgical Sciences recognizes the growing role of artificial intelligence (AI) and AI-assisted technologies in scientific research and scholarly communication. This policy establishes clear and transparent standards for the acceptable use of generative AI tools — including large language models (LLMs) such as ChatGPT, Gemini, Copilot, and similar systems — by authors, peer reviewers, and editors involved in the journal’s publication process.
This policy is aligned with the recommendations of the Committee on Publication Ethics (COPE; https://publicationethics.org/cope-position-statements/ai-author), the International Committee of Medical Journal Editors (ICMJE; https://www.icmje.org/news-and-editorials/icmje-recommendations-on-the-use-of-ai-in-scientific-publication.html), and the STM Association guidelines on generative AI.
This policy will be reviewed and updated regularly as the landscape of AI tools and their applications in scholarly publishing continues to evolve.
1. Policy for Authors
1.1. Permitted Uses
Generative AI and AI-assisted tools may be used solely to improve the language, grammar, readability, and clarity of manuscript text. Examples of permitted use include grammar checking, spell checking, and language editing for non-native English speakers.
1.2. Prohibited Uses
The following uses of AI are strictly prohibited:
- Generating, fabricating, or substantially writing any part of the manuscript content, including the Introduction, Methods, Results, Discussion, or Conclusion sections
- Producing, manipulating, or enhancing figures, images, clinical photographs, or graphical elements, except where AI is a defined component of the research methodology (see Section 1.4)
- Generating references, citations, or bibliographic data, as AI tools are known to produce inaccurate or entirely fabricated citations
- Conducting literature searches or systematic reviews without transparent documentation of the AI tool used and its limitations
- Using AI to interpret data or draw scientific conclusions
1.3. Mandatory Disclosure
Authors who have used any AI tool in the preparation of their manuscript must disclose this in a dedicated statement within the manuscript. This statement must appear in the Acknowledgments section and must specify:
- The name and version of the AI tool used (e.g., ChatGPT-4, Grammarly)
- The purpose for which it was used (e.g., language editing)
- Confirmation that the authors reviewed and verified all AI-generated content
Example disclosure statement: “During the preparation of this manuscript, the authors used [Tool Name, Version] for the purpose of [specific use, e.g., English language editing]. The authors reviewed and take full responsibility for all content in the manuscript.”
If no AI tools were used, no statement is required.
1.4. AI as Part of Research Methodology
When AI or machine learning tools constitute a component of the research itself (e.g., AI-assisted image analysis, diagnostic algorithms, predictive modeling), this must be described in full detail in the Materials and Methods section, including the name, version, training data, validation approach, and any known limitations of the tool.
1.5. Figures, Images, and Graphical Abstracts
AI-generated or AI-modified figures, clinical images, histological images, or radiological images are not permitted in manuscripts unless the AI tool is explicitly part of the study methodology, as described in Section 1.4. The use of AI to generate graphical abstracts is not permitted. AI-generated cover art may be considered only with prior written approval from the editor-in-chief, provided that the AI-generated nature of the image is clearly attributed.
1.6. Authorship
AI tools and AI systems cannot be listed as authors or co-authors of any manuscript submitted to this journal. Authorship confers accountability, and AI tools cannot fulfill the ICMJE authorship criteria, which require the ability to approve the final manuscript, accept responsibility for the work, and respond to questions regarding its integrity. Listing an AI system as an author will result in immediate rejection of the manuscript.
1.7. Author Responsibility
Authors bear full and sole responsibility for the accuracy, integrity, originality, and ethical compliance of their submitted work, regardless of whether AI tools were used in its preparation. The use of an AI tool does not diminish or transfer any aspect of this responsibility.
2. Policy for Peer Reviewers
2.1. Confidentiality Obligation
Manuscripts submitted for peer review are confidential documents that remain the intellectual property of the authors. Peer reviewers must not upload, share, or input any portion of a submitted manuscript — including text, figures, or data — into any external AI tool, platform, or language model. Doing so constitutes a breach of confidentiality and may expose the journal and its authors to violations of intellectual property rights and data privacy regulations.
2.2. Prohibition on AI-Assisted Review
Peer reviewers must not use AI tools to generate, draft, or substantially assist in writing their review reports. Peer review requires expert scientific judgment, critical thinking, and original assessment — responsibilities that cannot be delegated to automated systems. Reviewers are personally accountable for the content and quality of their evaluations.
2.3. Permitted Use
Reviewers may use standard grammar and spell-checking tools (e.g., Grammarly, built-in word processor tools) to improve the clarity of their written review, provided that no manuscript content is inputted into these tools.
2.4. Reporting Violations
Reviewers who become aware of potential AI policy violations — by themselves or others — are expected to notify the editorial office promptly.
3. Policy for Editors
3.1. Confidentiality Obligation
All manuscripts, reviewer reports, author correspondence, and editorial communications are strictly confidential. Editors must not upload any of this material to external AI tools or language models at any stage of the editorial process.
3.2. Prohibition on AI-Assisted Editorial Decisions
Editors must not use AI tools to evaluate manuscripts, assess scientific merit, or make acceptance or rejection decisions. Editorial decision-making requires expert human judgment and carries ethical and legal accountability that AI systems cannot assume. Editors are personally responsible for all editorial decisions made under their oversight.
3.3. Journal-Sanctioned AI Tools
The journal may use AI-assisted tools internally for specific administrative tasks, including similarity detection (plagiarism screening), spam filtering, and reviewer identification. All journal-sanctioned AI tools are selected with data privacy and confidentiality as primary requirements. These tools operate in compliance with applicable data protection standards and do not expose manuscript content to third parties.
3.4. Policy Enforcement
Editors who become aware of suspected violations of this AI policy — by authors, reviewers, or other editors — must report the matter to the editor-in-chief. Confirmed violations will be handled in accordance with COPE guidelines for research misconduct.
4. Amendments and Updates
The journal’s AI policy will be monitored and reviewed at least annually in response to developments in AI technology, evolving best practices in scholarly publishing, and updated guidance from COPE, ICMJE, and other relevant organizations. Authors, reviewers, and editors will be notified of any substantive policy changes via the journal website.
For questions regarding this policy, please contact the editorial office at editor@jocass.org.
Conflicts of interest
Journal of Cukurova Anesthesia and Surgical Sciences (J Cukurova Anesth Surg)
Overview
A conflict of interest exists when a participant in the publication process has financial, personal, professional, or institutional relationships that could inappropriately influence — or be perceived to influence — their judgment, decisions, or actions in that process. Conflicts of interest do not necessarily imply wrongdoing; however, transparency in their disclosure is essential to maintaining the integrity and credibility of the scientific record.
All participants in the peer-review and publication process at J Cukurova Anesth Surg — including authors, peer reviewers, editors, editorial board members, and editorial staff — are required to identify, disclose, and manage any actual or potential conflicts of interest in accordance with the guidelines of the International Committee of Medical Journal Editors (ICMJE; https://www.icmje.org/conflicts-of-interest/) and the Committee on Publication Ethics (COPE; https://publicationethics.org).
1. Authors
1.1. Disclosure Obligation
Authors are responsible for disclosing all financial and personal relationships that might bias, or be seen to bias, their work at the time of manuscript submission. This obligation applies to all manuscript types and all authors listed on the submission, including the corresponding author and all co-authors.
Relationships that must be disclosed include, but are not limited to:
- Employment or affiliation with any organization with a financial interest in the manuscript’s findings
- Consultancy fees, honoraria, or speaker’s bureau payments received from relevant companies or organizations
- Stock ownership or equity interests in companies related to the research
- Research funding, grants, or other financial support received from public, private, or commercial sources
- Patents held or pending that relate to the content of the manuscript
- Personal relationships (e.g., family members, close colleagues) with individuals who might benefit or be disadvantaged by the publication of the findings
- Travel grants or other benefits received from organizations with an interest in the research
1.2. Disclosure Form
Authors must complete and submit the ICMJE Disclosure Form for Conflicts of Interest at the time of submission. The form is available at: https://www.icmje.org/disclosure-of-interest/
A completed form must be submitted by every author individually. Conflict of interest disclosures will be published as part of the accepted article to ensure full transparency.
1.3. No Conflict of Interest
If no conflicts of interest exist, authors must explicitly state this in the manuscript using the following or equivalent wording: “The authors declare no conflict of interest.”
1.4. Funding Sources
All sources of financial support for the research must be disclosed in a dedicated Funding section in the manuscript. The role of each funding source in study design, data collection, analysis, interpretation, and the decision to submit for publication must be described. If the funding source had no involvement in any of these aspects, this must be explicitly stated.
2. Peer Reviewers
2.1. Disclosure Obligation
Peer reviewers must disclose to the editor any relationships or circumstances that could bias, or could be perceived to bias, their evaluation of a manuscript. This disclosure must be made at the time of accepting or declining a review invitation, before the review is undertaken.
Conflicts of interest that require disclosure include:
- Current or recent (within the past three years) collaboration with any of the authors
- Employment at the same institution as any of the authors
- Personal relationships with any of the authors (e.g., close friendship, family connection, mentorship)
- Financial interest in the outcome of the review (e.g., stock ownership, competing research programs, competing patents)
- Prior public statements or published opinions that could be seen to prejudge the manuscript
2.2. Recusal
Reviewers with a conflict of interest must decline the review invitation and notify the editorial office of the nature of the conflict, so that an alternative reviewer can be appointed promptly. Reviewers must not allow potential conflicts to influence their evaluation in any direction — neither toward unwarranted criticism nor toward unwarranted endorsement.
2.3. Prohibition on Misuse of Unpublished Information
Reviewers must not use knowledge of the work they are reviewing — including methods, data, conclusions, or ideas — to further their own interests before the manuscript is published. This constitutes a serious breach of confidentiality and research ethics and will be handled in accordance with COPE guidelines.
3. Editors and Editorial Staff
3.1. Editors
Editors who are responsible for making final decisions on manuscripts must recuse themselves from handling any submission in which a conflict of interest exists. Situations requiring recusal include:
- Manuscripts authored or co-authored by the editor themselves
- Manuscripts submitted by current or recent close collaborators, students, or mentors of the editor
- Manuscripts from the editor’s own institution where a direct benefit or disadvantage could arise
- Manuscripts related to research in which the editor has a financial interest (e.g., stock, patents, consultancy relationships)
- Any personal relationship that could bias the editorial decision
When a conflict of interest is identified, the manuscript must be transferred to another senior editor or a guest editor who has no conflict with the submission.
3.2. Editorial Board Members
Editorial board members who participate in editorial decisions must provide the editor-in-chief with an up-to-date description of their financial interests and any other relationships that might constitute a conflict of interest. Board members must recuse themselves from any decision in which a conflict of interest exists and must inform the editor-in-chief of the nature of the conflict.
3.3. Guest Editors
Guest editors handling manuscripts for special issues or supplements are subject to the same conflict of interest requirements as regular editors. Guest editors must disclose all potential conflicts of interest to the editor-in-chief before assuming editorial responsibilities for any submission.
3.4. Editorial Staff
All members of the editorial staff who have access to submitted manuscripts or who participate in any aspect of the editorial process must not use information gained through their work for private gain. Editorial staff must disclose any relationships or circumstances that could constitute a conflict of interest to the editor-in-chief and must recuse themselves from any process in which such a conflict exists.
3.5. Public Disclosure
The editor-in-chief will publish regular disclosure statements summarizing potential conflicts of interest related to their own professional commitments and those of journal staff and editorial board members. These statements will be made available on the journal’s website and updated at least annually.
4. Handling Undisclosed Conflicts of Interest
If an undisclosed conflict of interest is identified after submission, during peer review, or following publication, J Cukurova Anesth Surg will investigate the matter in accordance with COPE guidelines. Depending on the nature and severity of the undisclosed conflict, actions may include:
- Requesting a formal explanation from the relevant party
- Issuing a correction or editorial expression of concern
- Retraction of the published article
- Notification of the author’s or reviewer’s institution
Authors, reviewers, and editors who become aware of an undisclosed conflict of interest at any stage of the process are encouraged to report it to the editorial office in confidence.
5. Related Resources
- ICMJE Conflicts of Interest disclosure form: https://www.icmje.org/disclosure-of-interest/
- ICMJE recommendations on conflicts of interest: https://www.icmje.org/conflicts-of-interest/
- COPE guidelines on conflicts of interest: https://publicationethics.org/guidance/Guidelines
- WAME conflict of interest policy: https://www.wame.org/conflict-of-interest-in-peer-reviewed-medical-journals
This policy applies to all manuscript types considered for publication in J Cukurova Anesth Surg. For questions regarding conflicts of interest disclosure, please contact the editorial office at editor@jocass.org.
Open access, copyright and self-archiving
Journal of Cukurova Anesthesia and Surgical Sciences (J Cukurova Anesth Surg)
Commitment to Open Access
J Cukurova Anesth Surg is a fully open-access journal. The journal adheres to the Budapest Open Access Initiative (BOAI; http://www.budapestopenaccessinitiative.org) and defines open access in accordance with the original BOAI declaration:
“By ‘open access’ to peer-reviewed research literature, we mean its free availability on the public internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself.”
All articles published in J Cukurova Anesth Surg are freely and permanently accessible online immediately upon publication, without subscription fees, registration requirements, or any other access barriers.
Licence and prospective transition
Articles covered by this policy are published under the Creative Commons Attribution-NonCommercial 4.0 International licence (CC BY-NC 4.0). This permits sharing and adaptation for non-commercial purposes with appropriate attribution, a link to the licence and an indication of changes. No additional restrictions are imposed beyond the licence. Third-party material excluded from the licence must be identified with its applicable terms.
Effective 12 September 2026, this policy applies prospectively to articles first published by JOCASS on or after that date. Articles published before that date retain the copyright and licence terms stated on the individual article at the time of publication. Previously signed agreements are not amended automatically; for unpublished manuscripts covered by an earlier transfer form, an updated publication licence must be agreed before publication under the new policy.
Current author fees
No submission or publication fees are currently charged, including article processing, editorial processing, page or colour charges. Any future fees, their effective date and applicable waiver or discount arrangements will be announced before submission and will apply only to submissions received under the announced fee policy. Fee status, payment or waivers will not influence editorial decisions.
Self-Archiving and Repository Policy
In line with BOAI recommendations, authors are encouraged to deposit their published articles — or the accepted manuscript version — in institutional or disciplinary repositories (e.g., PubMed Central, Zenodo, institutional repositories) immediately upon publication. The published PDF version (Version of Record) may be self-archived, provided that the original publication in J Cukurova Anesth Surg is properly acknowledged and a link to the published article is included.
Copyright and author agreement
Authors retain copyright and grant JOCASS the right of first publication and the non-exclusive rights necessary to publish, reproduce, distribute, communicate and archive the article in print and electronic formats. Copyright and economic rights are not transferred to the journal.
All authors must agree to the JOCASS Publication License and Author Declaration Form before publication. The bilingual English–Turkish PDF and author forms and templates are available directly on JOCASS. During the form transition, contact the editorial office if an earlier transfer form is displayed in the submission system.
New article HTML, PDF and licence metadata must use: © [year] The Author(s). Published by JOCASS. Licensed under CC BY-NC 4.0. Link to https://creativecommons.org/licenses/by-nc/4.0/.
Journal Metrics and Impact
Consistent with BOAI recommendations and ICMJE guidelines, J Cukurova Anesth Surg discourages the use of journal impact factor as the sole indicator of research quality or journal standing. The journal supports the development and use of article-level metrics and alternative indicators of research impact that more accurately reflect the reach and significance of individual contributions.
Further Information
For questions regarding the journal’s open access policy, licensing terms, or self-archiving rights, please contact the editorial office at editor@jocass.org.
Budapest Open Access Initiative: http://www.budapestopenaccessinitiative.org Creative Commons CC BY-NC 4.0: https://creativecommons.org/licenses/by-nc/4.0/
Author charges
No fee is charged from the author or institution under any name.
No submission or publication fees are currently charged, including article processing, editorial processing, page or colour charges. Any future fees, their effective date and applicable waiver or discount arrangements will be announced before submission and will apply only to submissions received under the announced fee policy. Fee status, payment or waivers will not influence editorial decisions.